Press

                                                                      September 16, 2017                                                                   Witty Health Inc. Announces Regulatory Submission of a Digital-Drug Combination Product for Metastatic Breast Cancer

————————————————————————-

August 17, 2017
Witty Health Inc. announces the initiation of clinical development of a novel Fulvestrant Cancer Treatment Platform for metastatic breast cancer


July 7, 2017
Witty Health Inc. Appoints Karthik Koduru, MD as Chief Oncologist as Company Extends its Monitoring Platform to Oncology Market


April 20, 2017
Witty Health Inc. Launches an Intelligent Remote Health Risk Monitoring Platform